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PHILIPP MCCONNELL SUMMERS.  Extensive and Persistent Disruption of 




Cerebral microinfarcts (CMI), microscopic brain lesions caused by blockade of small 
blood vessels, have recently emerged as a potential determinant of cognitive 
decline. Though small in size, our recent work demonstrated that a single, 
strategically placed CMI was sufficient to disrupt sensory input in a behavioral task. 
However, the means by which such small lesions disrupt brain function remain 
poorly understood. We imaged vascular function in awake, head-fixed mice using 
two-photon microscopy to examine the impact of CMI on neurovascular coupling. 
CMI were generated in cortex by photothrombotic occlusion of single penetrating 
vessels through a thinned-skull cranial window. Vibrissa-evoked dilation of individual 
arteries and arterioles within the primary vibrissa cortex were tracked over four time 
periods: pre-occlusion, acute (2-3 days post-occlusion), subacute (7-9 days) and 
chronic (14-21 days). In the acute phase, dilatory responses were markedly 
attenuated compared to pre-occlusion (2.2 ± 0.5% mean dilation over baseline vs. 
11.2 ± 0.8%, p < 0.001). Dilatory responses during the subacute (7.8 ± 1.1%) and 
chronic (6.5 ± 1.1%) phases partially recovered but remained significantly attenuated 
in magnitude and time to dilation compared to pre-occlusion (p < 0.01). Critically, 
vascular dysfunction was observed well beyond the borders of the CMI, as infarcts 
with an average radius of 0.19 ± 0.05 mm generated deficits in dilation at distances 
exceeding 1 mm away from the vessel targeted for occlusion.  Analysis of dilations in 
a separate cohort of mice during the hyperacute time period (0-3 hours post-
occlusion), revealed that the dilatory deficit is first expressed in the immediate 
vicinity of the stroke and then propagates outward from the occlusion site. While 
unresponsive to sensory stimulation, vasodilation could be evoked by isoflurane 
inhalation, albeit attenuated in the subacute phase (156.7 ± 5.3% of pre-stroke levels 
vs. 134.6 ± 4.3% subacute, p = 0.02). Expression of c-Fos following an extended 
period of vibrissa stimulation was reduced in the peri-infarct tissue in the acute time 
period, with gradual recovery initiating distal to the stroke apparent in subacute and 
chronic mice.  This indicated that loss of sensory-evoked vasodilation is attributed to 
a combination of altered vascular mechanical properties and a deficit in neural 
connectivity and/or activity. Thus, CMI disrupt brain function well beyond the regions 
of overt tissue infarction and this effect, combined with their widespread distribution 
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Vasculature of the Brain 
 
The constant energy demands of brain function must be supplied by a 
reliable and dynamic cerebrovascular system (1). The cerebral cortex is supplied 
by the great cerebral arteries that emanate from the Circle of Willis and source a 
planar network of highly interconnected pial arterioles on the brain surface (2). 
Blood flow in this network is relatively insensitive to blockages (3, 4), and also 
permits the dynamic redistribution of blood toward regions of heightened 
electrical activity (5,6).   
 
Figure 1.  Vasculature of the mouse cortex.     
 (A) Vasculature of the dorsal surface of the of the whole mouse brain revealed by a fluorescein-
gelatin cast.  (B)  Schematic of the three-tiered topology of vasculature in the mouse cortex, 
containing highly interconnected surface pial networks, penetrating vessels which create 
bottlenecks in flow, and subsurface microvascular networks.  Adapted from Blinder et al. (7).(C) 
Illustration of penetrating vessels projecting radially from the pial surface into deep layers of the 
cortex Adapted from Shih et al. (8). 
These pial vessels are in turn connected to an underlying, three-
dimensional network of microvessels by penetrating arterioles that project radially 
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from the surface, as shown in Figure 1B , forming bottlenecks in flow to columns 
of cortical microvasculature (7). Blood is drained from the microvasculature back 
to the cortical surface through penetrating venules and then emptied into the 
central sinus.  
The physiological demands served by the blood supply of the brain are 
particularly significant because neurons are more sensitive to oxygen deprivation 
than other kinds of cells with lower rates of metabolism (9).  The brain is also at 
risk from circulating toxins, and is specifically protected in this respect by 
the blood-brain barrier.  In addition to having a high metabolic rate, neurons 
obtain virtually all of their nutrition via aerobic metabolism of glucose, making 
them even more reliant on persistent oxygenation (10).  When blood supply is 
compromised, deprivation of oxygen and glucose may cause transient or 
permanent damage to brain tissue.  Even a brief loss of blood supply can initiate 
cellular changes which lead to cell death, while a prolonged loss of blood flow 




Cerebral metabolism depends on a constant supply of both glucose and 
oxygen. A continuous supply of these two energy substrates is maintained by 
cerebral blood flow (CBF), which delivers glucose and oxygen to neural tissue 
through the complex web of blood vessels in the brain’s vascular system.  
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Accordingly, during neural activity, increases in oxygen and glucose consumption 
are followed by an increase in CBF (11). While the increase in CBF is 
comparable to the rise in glucose consumption rate, the rate of oxygen 
consumption is fractionally smaller in magnitude, resulting in an increase in the 
relative concentration of oxygen in blood and tissue (12). This oversupply of 
oxygen due to the mismatch between CBF and oxygen consumption is the basis 
of blood-oxygenation level dependent (BOLD) fMRI, which detects alterations in 
levels of deoxygenated hemoglobin and cerebral blood volume (13, 14). 
 
The Neurovascular Unit 
 
 Neurovascular coupling is accomplished through the activity of a group of 
cells, closely related to each other, called the neurovascular unit (NVU).  The 
NVU is composed of neurons, astrocytes, endothelial cells of the blood-brain 
barrier (BBB), myocytes, and pericytes (15).  These components exhibit a tightly 
linked anatomical and chemical relationship that detects neuronal metabolic 
needs and triggers the necessary vasodilatory or vasoconstrictive response 
needed to regulate nutrient distribution and meet such demands. The NVU has 
also been implicated in eliciting selective changes in BBB permeability, either 
through direct signaling from neurons or alternative pathways through pericytes 




2-Photon Imaging as a Tool to Study Neurovascular C oupling 
 
Two-photon laser-scanning microscopy (TPLSM) is an imaging technique 
which combines the point-by-point rastering technique of confocal laser scanning 
microscopy with physical phenomena of two-photon absorption, which is the 
simultaneous absorption of two photons to excite a molecule from one state to a 
higher energy electronic state (17).  As a result of this phenomenon, the two 
excitation photons can provide the excitation of a photon with twice their own 
energy.  Many fluorescent markers used in in-vivo imaging require excitation light 
in the visible spectrum, which is scattered at relatively shallow depths in brain 
tissue.  Two-photon microscopy allows researchers to circumvent these issues 
by providing excitation for the same fluorophores from the infra-red spectrum by 
way of two-photon absorption, permitting greater depth of imaging with less 
scattering of excitation light (18).   
The depth of imaging allowed by two-photon microscopy, combined with 
the high spatial-acuity of laser scanning microscopy, make this imaging method 
one of the most amenable for imaging living tissue up to a very high depth.  Due 
to multiphoton absorption, the background signal is strongly suppressed, 
resulting in improved light detection efficiency, and reduced phototoxicity 
compared to confocal microcopy.  In vivo TPLSM is already an established 
method to visualize cerebrovascular topology and quantify blood flow at the level 
of single vessels in the rodent cortex, and is an excellent tool for probing 






A stroke is defined as the loss of brain function due to a disturbance in the 
blood supply to the brain (19).  This can arise either from ischemia, a lack of 
blood flow due to a clot or general hypoxia, or hemorrhage, a loss of blood flow 
due to rupture of a vessel.  The majority of strokes (87%) are ischemic strokes.  
Every year, about 800,000 people in the United States have a stroke (20).  While 
stroke is the fourth leading cause of death in America, killing nearly 130,000 
individuals each year (21), a large proportion of patients survive its devastating 
effects and require rehabilitation and long-term care to overcome disabilities.  As 
a result, stroke is a great burden to the economy, costing the United States an 
estimated $36.5 billion annually (22).   
 
The Ischemic Cascade 
 
The progression of stroke injury is very complex, involving various 
mechanisms of cell death including excitotoxicity, apoptosis, necrosis and 
inflammation.   Following the loss of blood supply, stroke begins with the 
disruption of metabolism and homeostasis in neurons and glia due to an inability 
to generate adequate levels of adenosine triphosphate (ATP) (23).  The loss of 
ATP-dependent ion channel activity results in a breakdown of ionic gradients 
across the plasma membrane, resulting in widespread depolarization of neurons 
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and glia and subsequent uncontrolled release of synaptic glutamate (24, 25).  
The loss of membrane potential also shuts down Na+-dependent glutamate 
transporters, preventing reuptake and further exacerbating extracellular 
glutamate accumulation (26).   
The rise in glutamate initiates a toxic secondary cascade known as 
excitotoxicity (27, 28).  The elevated levels of glutamate over-stimulate NMDA 
and AMPA-type neuronal glutamate receptors, leading to an influx and 
accumulation of Ca++ in the cytosol (29).  Intracellular Ca++ overload leads to 
mitochondrial dysfunction, compounding the issue of ATP depletion and 
triggering the apoptotic cascade. 
Cortical spreading depression (CSD) is an intense depolarization wave 
that slowly propagates through gray matter. CSD is characterized by a wave of 
hyperactivity followed by a wave of depression (30), and is associated with 
massive transmembrane ionic and water shifts coupled to a surge in extracellular 
K+ (31).   CSD has been found to coincide with tissue hypoxia (32), and 
incidences of spreading depression, sometimes termed “injury depolarizations”, 
have been detected in the human brain following ischemic stroke, subarachnoid 
hemorrhage, intracerebral hemorrhage, and traumatic brain injury (33).  In 
ischemic stroke, spreading depressions seem to originate at the junction 
between the ischemic core and the moderately ischemic penumbra, where 
synaptic activity has ceased, but some neuronal membrane potentials are 
preserved.  These depolarizations propagate along the infarct rim and often into 
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non-ischemic tissue, exerting metabolic and hemodynamic effects that can 
worsen the long-term outcome of ischemic tissue (34). 
In ischemic stroke, the reduction of CBF is most pronounced in the 
ischemic core, while it is less pronounced in the periphery (35).  Following focal 
and global ischemia, when perfusion is reestablished in the peri-infarct, there is a 
transient increase in flow followed by a period of reduced flow.  After ischemia, 
cerebral circulation experiences some degree of vasoparalysis (36).  It has long 
been known that, following ischemic stroke, the reactivity of cerebral circulation 
to administration of carbon dioxide and vascular autoregulation is altered and 
impaired in patients (37).  Studies that assess indices of neural activity in patients 
suggest that the reduction in neurovascular coupling may be secondary to a 
reduction in the neural activity driving the hemodynamic response (38).  It has 
also been found that the increase in glucose utilization typically evoked by 
vibrissa stimulation of rats is severely depressed one day following transient 
global ischemia (39), indicating that, in addition to a depressed CBF response, 
metabolic responses are attenuated following stroke.  Small cortical strokes have 
been found to produce a broad region of hypometabolism, termed diaschisis, 
outside of the putative ischemic core (40).  It is postulated that this is due to 
vascular steal (41), or the loss of the CBF to neighboring hypometabolic regions, 
and a deficit in neural activity resulting from the loss of afferents that previously 
emerged from the stroke core (42). 
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CSD may, to some extent, drive these effects, as it has been found to 
elicit a strong vasoconstrictive response in the peri-infarct tissue (43).  
Widespread vascular oxidative stress could also contribute to loss of 
neurovascular coupling.  Ischemia leads to an increase of reactive oxygen 
species (ROS), which can cause profound alterations in cerebrovascular 
regulation (44), while ROS scavengers ameliorate disturbances in CBF following 
ischemia-reperfusion (45). 
 
Effects of Anesthetics on Stroke  
 
Anesthesia alters key mechanisms of stroke injury and repair, and will 
therefore affect the trajectory of the disease. In the acute stage of ischemic 
injury, this can occur by suppression of neuronal activity or by engaging collateral 
blood flow sources. Common anesthetics, such as isoflurane, reduce the 
cerebral metabolic rate for oxygen consumption and likely the extent of 
excitotoxic neuronal toxicity (46). Ketamine, in particular, is an antagonist of the 
NMDA receptor and attenuates production of the potent vasomediator, nitric 
oxide, during stroke (47).  The frequency of CSD events has been shown to be 
attenuated or modulated by numerous anesthetics, including ketamine (48, 49), 
volatile anesthetics halothane, isoflurane and sevoflurane (50, 51), and urethane-
chloralose (52). Thus, many anesthetics mediate an overall protective effect in 
stroke by attenuating excitotoxic injury (53).  
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Anesthesia can also affect CBF, which may have opposing effects on 
stroke outcome. Pentobarbital and isoflurane, in particular, cause global cerebral 
vasodilation and a significant reduction in CBF that lead to a hypoperfusion (54).  
In the setting of a stroke, this could conceivably decrease perfusion in the stroke 
penumbra, exacerbating injury. Conversely, the dilation of cerebral arterioles can 
conceivably promote tissue survival by engaging collateral blood supply to the 
hypoxic tissue.  Another important consideration is that hemodynamic responses 
measured by BOLD fMRI are widely used to infer tissue recovery after stroke 
(55). Given the suppressive effects of anesthetics on arterial and neuronal 
reactivity, it is unclear when models using anesthesia fail to mimic the human 
condition (56, 57).  
The effects of anesthetics can extend beyond the acute phase of stroke 
when the infarct stabilizes and the peri-infarct zone begins to recover. 
Longitudinal in vivo imaging studies typically involve repeated periods of 
anesthesia that could affect repair/recovery processes. Anesthetics impact the 
activity of microglia directly by altering the expression of inflammatory mediators 
and also indirectly by reducing CSD, which promotes microglial activation (58).  
The effect varies with the type of anesthetic used, as isoflurane appears to 
promote cytokine expression (59, 60), while ketamine has an inhibitory effect 
(61).  Further, the activity of microglia is tightly linked to post-stroke repair 
process through release of matrix metalloproteinases, which are associated with 
the breakdown of tight junction proteins in acute stroke (62), but also appear to 
10 
 
be involved in remodeling of neuronal connectivity (63) and possibly nascent 
blood vessel formation (64). 
One limitation in current preclinical stroke studies is that the models are 
often invasive, necessitating deep and prolonged anesthesia. This precludes the 
visualization of early changes in stroke, and can dictate the extent and long-term 
trajectory of the injury.  To minimize the confounding influence of anesthetics in 
this study, mice were imaged and vessels were occluded in the awakened state, 





Cerebral microinfarcts (CMIs) are tiny lesions characterized by genuine 
tissue infarction, but on a scale that renders them unapparent in gross pathologic 
examination or conventional structural MRI, although there is evidence that in 
vivo detection of microinfarcts might soon be possible (65).  Though many 
studies have shown that asymptomatic microinfarcts and cerebrovascular 
disease are very common, especially with aging, these “silent” strokes are nearly 
twice as prevalent in cases of dementia as in the healthy, aged brain (66, 67).  
While the clinical relevance of CMIs has been controversial, there is a growing 
body of evidence that they impart a deleterious effect on cognitive performance.  
In a study where CMIs were introduced in the rat barrel cortex, it was found that 
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a single microscopic lesion, similar in size, location and geometry to a human 
microinfarct, could produce tissue damage and perceptual deficits which could be 
mitigated with administration of memantine, a glutamate receptor antagonist (68). 
 
Targeted Photothrombotic Occlusion 
 
Targeted photothrombotic occlusion is a method by which ischemic 
damage is induced within a targeted cortical area by means of photo-activation of 
a previously injected light-sensitive dye.  The dye Rose Bengal (4,5,6,7-
tetrachloro-2',4',5',7'-tetraiodofluorescein) is one such photo-sensitizing agent.  
When Rose Bengal dye is illuminated with a 530nm laser, singlet oxygen is 
produced.  In the intravascular environment, these free radicals damage 
components of endothelial cell membranes, leading to platelet aggregation and 
thrombi formation, eventually interrupting local blood flow (69).  While diffuse light 
exposure has been used to generate large, non-specific strokes, emerging 
methods have been introduced to produce much smaller strokes, which mimic 
the nature of a CMI (70, 71).  Using dichroic mirrors, a focused green laser may 
be introduced into the same optical pathways as the imaging laser used in a 
TPLSM system, allowing for photothrombosis to be targeted specifically to the 
lumen of an individual penetrating vessel (72).  Following occlusion, the injury 







For this study, male mice from the C57BL/6 line were selected for use. 
Mice selected for the study were between 3 to 7 months of age at the time of the 
initial surgery, with an average age of 4.7 ± 1.2 months.  The mean weight of the 




Prior to the study, the timeline in Figure 2  was developed to schedule 
surgery, habituation, and imaging.  On day one, mice were implanted with a 
head-fixation flange imbedded in a skull cap.  However, at this time a chronic 
window was not created in the skull to mitigate the deterioration of imaging 
quality later in the experiment.   
 
Figure 2.  Timeline of experimental procedures  
The initial surgical procedure was followed by four days of habituation to 
head fixation to prepare the mice for awake imaging sessions.  On day four of 
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habituation, a PoRTS window was created over the left hemisphere of the 
mouse.  The following day, pre-occlusion imaging was initialized, after which a 
single CMI was induced using photothrombosis in the barrel cortex.  Post-
occlusion imaging was then carried out in three time phases: acute (2-3 days 
post-occlusion), subacute (7-9 days), and chronic (14-17 days).  Following the 
completion of chronic imaging, mice were sacrificed and perfused, and the tissue 
was labeled using immunohistochemistry techniques. 
 
Surgical Procedure – Head Mount Implantation 
 
Prior to the initiation of habituation, surgical procedures were performed to 
create a skull cap and implant a head-mount flange.  Mice were first anesthetized 
with 4% isoflurane in air in an enclosed container.  Once mice were in an 
anesthetized state as determined by the toe-pinch test, they were transferred to 
an apparatus under the surgical microscope with 1-2% isoflurane in air provided 
through a nose cone.  At this time, mice were given a 50µl dose of .03mg/ml 
analgesic Buprenex (buprenorphine).  The scalp of the mouse was sterilized with 
betadine followed by 30% ethanol.  The toe-pinch test was performed again to 
ensure adequate depth of anesthesia before making any incision.  Forceps were 
used to pinch and lift the scalp, which was removed with a single, clean incision 
using scissors.  If any bleeding occurred at this point, sterilized kimwipes were 
employed to stop the flow of blood and to clean up the surgical site.   
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Sharp forceps were then used to remove the peri-osteum from the surface 
of the skull, exposing the bone. The skull surface was scored over the right 
hemisphere using the sharp forceps to allow for stronger binding with glue and 
dental cement.  Additionally, the surface of the skull over the stereotaxic location 
of the vibrissa sensory cortex (3.5-4.0mm lateral from the midline and 1.2-2.0 
mm caudal to bregma) was marked with a sterilized pencil.  A wooden applicator 
was used to brush a thin layer of cyanoacrylate glue over the junction of the 
exposed skull and the edge of the incision, as well as over the top of pronounced 
sutures in the skull.  This step is necessary to lock fluids away from the surface 
of the skull, which is critical when later creating the PoRTS window.   
After allowing the cyanoacrylate glue to dry for 15 minutes, a custom 
titanium head mount flange was positioned over the right hemisphere of the skull, 
above the scored hash marks.  Parkell C&B Metabond self-curing dental cement 
was applied to the exposed skull, with larger amounts about the head mount 
flange to anchor it to the skull.  A thin layer was brushed over the demarcated 
vibrissa cortex, allowing the region to still be visually identifiable while protecting 
the skull from open exposure.  The mice were then removed from the surgical 
apparatus and placed in their home cage under a heat lamp for recovery. 
Habituation to Head Fixation 
 
Following recovery from the initial surgery, the mice were gradually 
introduced to the long-term head fixation necessary for awake imaging in this 
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study.  On each day, mice were placed into the imaging apparatus as detailed in 
Figure 2 .  Following brief isoflurane exposure, the mice were fixed to an 
anchored arm using the head mount flange and an adjustable cardboard tube 
was positioned snugly around the bodies of the mice to minimize movement.  
Mice that would later wear the pulse oximeter during imaging were conditioned 
with the MouseOx fixed to the left leg as well.  On day one, habituation was 
carried out for 15 minutes, followed by 30 minutes on day two, 1 hour on day 
three, and 2 hours on day four.  At the end of day four of habituation, mice that 
exhibited characteristics indicative of proper habituation were selected for PoRTS 
window surgery. 
 
Surgical Procedure – PoRTS Window Surgery 
 
Prior to the second surgical procedure, mice were anesthetized using the 
same techniques utilized before creating the skull cap and implanting the head-
mount flange.  Once mice were determined to be properly anesthetized using the 
tail pinch test, they were secured to the surgical apparatus using the head-mount 
flange.  A dental drill was used at 10,000 rpm to delicately remove the dental 
cement over the demarcated vibrissa cortex.  After removing the dental cement, 
exposing the underlying bone, the drill tip was replaced, as wear and tear 
resulting from drilling through the cement could be deleterious when drilling 
through bone.  The skull was gradually thinned, periodically clearing debris using 
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an air canister and applying cool ACSF to the skull surface to dissipate heat 
created through the friction of drilling.  The skull was determined to be 
adequately thinned when microvasculature became clearly visible with no 
aberrations following the application of ACSF, indicating a width of about 10-20 
µm.  The skull was then dried using kimwipes and the air canister.  As shown in 
Figure 3 , a thin layer of cyanoacrylate glue was applied to the thinned skull and 
a No. 0 coverslip was placed over the glue, resulting in a clear optical interface. 
 
Figure 3.  Schematic of PoRTS window for imaging mo use cortex.  
Schematic showing the cross section of a PoRTS window.  A thin layer of glue was applied to the 




Imaging was performed using a custom Sutter two-photon microscopy 
setup powered by a tunable Coherent Ti-Sapphire laser.  The freeware package 
MPScope 2.0 was used to control the laser scanning system (74, 75).  Images 
and movies collected using this program were stored as .MPD files, a custom file 
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type, which allows for images across multiple channels to be packaged with co-
synchronous signals if desired. 
Mice were fixed into an imaging apparatus using the head mount flange 
and were additionally restrained with an adjustable cardboard tube.  As shown 
below in Figure 4 , an ADXL accelerometer was fixed to the cardboard tube to 
capture any strong incidences of movement, which may produce imaging 
artifacts during the study.  An air puffer, supplied by a custom air-puffing system, 
was place 2cm in front of the right vibrissa of the mice.  An additional air puffer 





Figure 4.  Schematic of Imaging Setup.   
A tunable Ti-Sapphire laser provides excitation in the infrared range (800nm excitation was used 
for this study).  Excitation light, which passes through the long-pass (700 nm cut-off) dichroic 
mirror, is focused, through the objective, to a very fine point which is rastered by scanning 
mirrors.  Emission light passes back through the same objective, but is reflected by the dichroic 
mirror due to a higher wave frequency (shorter wavelength).  Data was collected from the PMTs 
by an imaging computer, which was also used to drive the air-puff system.  The imaging 
computer was linked to an auxiliary computer, which collected data from an ADXL accelerometer 








At each time frame, imaging was performed in imaging sessions that did 
not exceed 4 hours over the course of one or more days.  Prior to fixation in the 
imaging apparatus, mice were anesthetized in an enclosed container with 4% 
isoflurane until a deep plane of anesthesia was reached as determined by the toe 
pinch test.  Once anesthetized, 0.05mL of 5.0% 2MDa FITC-dextran in PBS was 
introduced using a retro-orbital injection.  If a noticeable deterioration in imaging 
quality attributable to declining dye concentrations was noticed during imaging 
sessions, the mouse was anesthetized with a nose-cone and re-injected with 
FITC. 
Imaging of arteriole dilations was performed with a 20x Olympus objective 
with 1.0x digital zoom, a 512x400 pixel (312 x 244µm) imaging field, and a frame 
acquisition rate of 4.34 fps.  For imaging with FITC-dextran, the excitation laser 
was tuned to 800nm and emissions were collected with a PMT with a filter 
passing green wavelengths. 
Air puffers were supplied with 35 P.S.I. air and programmed to provide an 
8 Hz duty cycle of 20ms open, 105ms closed, for 10 seconds.  Areas of interest 
were determined by locating branching arterioles that exhibited a noticeable 
dilatory response to vibrissa stimulation.  Four to six regions of interest were 
located per animal during pre-occlusion imaging. 
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To determine the dilatory properties of arterioles in each region of interest, 
a randomized stimulation paradigm consisting of 20 x 2-minute trials was 
performed.  As shown in Figure 5A , each individual trial consisted of an initial 
baseline period of 30 seconds followed by 10 seconds of stimulation.  After 
stimulation, a 50 second recovery period was included to allow arteriole 
conditions to recover to baseline. For each trial, the stimulation type was semi-
randomized between vibrissa and tail stimulation so that 10 trials of each type 
occurred.  Each individual trial was recorded as an individual .MPD file.  
Following photothrombotic occlusion, the stimulation paradigm was carried 






Figure 5.  Stimulation Paradigm and Example of Dila tion.   
(A)  Stimulation trials consisted of a 30 second pre-stimulation period, a 10 second stimulation 
period, and an 80 second post-stimulation period.  20 randomized trials, consisting of 10 vibrissa 
stimulations and 10 tail stimulations, were carried out to assess each region of interest.  An 
additional 2 minute video was taken without stimulation to assess the quiescent behavior of the 
arterioles.  (B)  Example of arterioles dilating during vibrissa stimulation with traces showing 






 Following the completion of pre-occlusion imaging, the mice were briefly 
anesthetized with 3% isoflurane in air supplied through a nosecone.  Once a 
deep plane of anesthesia was reached, 0.025mL of 1.25% rose Bengal dye in 
PBS was injected retro-orbitally.  Immediately after injection, isoflurane was 
discontinued.  To aid in localization of the stroke to the barrel cortex, a 
penetrating arteriole previously observed to have a dilatory response to vibrissa 
stimulation was selected for targeted occlusion.  After targeting the chosen 
arteriole with the two-photon system, a 530nm green laser was introduced along 
the microscope’s light path with a moveable mirror, and focused through the 
objective to a point, 20µm in diameter, at the imaging plane, shown in Figure 6 . 
The power of the green laser at its focus was 1 mW. The targeted penetrating 
arteriole was exposed to the laser for 30-45 seconds, during which the laser 
induced photolytic activation of circulating rose Bengal dye, creating free 
radicals, which in turn irritated the vascular wall initiating the clotting cascade.  
After laser exposure, the two-photon system was used to image the 
targeted arteriole again to determine if occlusion was successful.  If the arteriole 
failed to occlude, the vessel was targeted for green laser exposure again.  Rose 
Bengal dye, which has a very short half-life, was re-injected, under anesthesia, if 
occlusion could not be achieved within 15 minutes.  Mice were again briefly 




Figure 6.  Schematic of Targeted Photothrombotic Oc clusion of an Arteriole.   
Intravenous Rose Bengal was activated with a green laser to produce ROS, causing vascular wall 




Prior to analysis, output .MPD files were converted to a .tiff format for 
compatibility with matlab processing techniques.  A custom matlab program was 
designed to handle bulk analysis of dilation data.  As demonstrated in Figure 7 , 
diameters of arterioles were determined by measuring the full-width half-
maximum of the vessels.  That is, the distance, when moving across the width of 
the vessel, from the first pixel that exceeds 50% of the intensity of the brightest 
pixel in the same cross-section, to the last such pixel. 
Using a custom matlab program, the diameters of any number of arterioles 
within the imaging region could be measured by determining the average full-
width half-maximum value for vessels within user-selected ROIs.  As an output, 
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this analysis program gave a data structure containing individual diameter traces, 
such as those in Figure 8 , for each vessel analyzed in each video. 
 
Figure 7.  Example of Full-Width Half-Maximum Measu rements of Dilating Arterioles 
(A)  Two-photon image of the pial network of surface vasculature, indicating two regions of 
interest (ROIs) positioned over surface arterioles.  (B)  Shading vessels in the image, with 
arterioles in red and venules in blue.  (C)  Full-width half-maximum  (FWHM)measurements over 
before, during, and after vibrissa stimulation in the ROIs indicated in A.  (D)  Lumen diameter of 
the vessels within the ROIs over the course of a stimulation trial, as measured by FWHM. 
 
A second custom program was utilized to compile data from these 
structures into average diameter traces for each vessel.  After selecting a 
particular vessel from a region and a stimulus type (vibrissa or tail), the program 
incorporates Labchart output data from the ADXL accelerometer to screen out 
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data traces that contain movement artifacts which may cause aberrations.  An 
average trace was then compiled from valid trials for the selected vessel.   
Several parameters were calculated from these average diameter traces 
for analysis in this study.  First, the average baseline diameter was calculated by 
taking the average diameter of the arteriole over at least 10 seconds during 
which spontaneous dilation does not occur during the 30 seconds preceding 
stimulation.  The maximum dilation diameter and mean dilation diameter were 
taken as the maximum and mean diameter of the arteriole during the 10 seconds 
of stimulation.  The maximum dilation percentage and the mean dilation 
percentage were calculated as the percent increase over the previously 
calculated baseline average for the two values.    
To assess the temporal coupling of stimulus to response, the latency to 
dilation was calculated for each trace as the amount of time, in seconds, that 
elapses from the initiation of stimulation to the time point at which the arteriole 
diameter exceeds two standard deviations above the baseline average. 
Calculation of these parameters was automated and incorporated as a 







Figure 8.  Vibrissa Stimulation Elicited Robust Dil ation in Arterioles within the Vibrissa 
Cortex. 
Dilatory traces from a single vibrissa stimulation trial in two arterioles.  Accelerometers affixed 
to the restraint tube indicate no significant movement.  Multiple trials are averaged using a 
custom program, and the latency to dilation, mean dilation, and max dilation are calculated 








Following the completion of the chronic imaging session, the mice were 
injected with 0.1 mL of Euthasol and then trans-cardially perfused with 60mL 
PBS followed by 10mL 4% paraformaldehyde in PBS.  The brain was then 
extracted and bisected into hemispheres.  The cerebellum and striatum were 
delicately removed using forceps, and the remaining cortical hemispheres were 
flattened between two microscope slides separated by 1/16” and anchored 
together with two pairs of magnets placed at both ends of the slides.  The 
microscope slide was then placed in a 60ml conical tube, submerging the brain 
tissue in 4% paraformaldehyde (15mL were added to each conical).  The conical 
was then stored overnight at 4oC.  After 24 hours, the 4% paraformaldehyde 
solution was replaced by PBS, and the conical tube was stored at 4oC until tissue 
was used for histology. 
Prior to immunohistochemistry, flattened cortices of both hemispheres 
were removed from the microscope slides and sliced into 50µm sections using a 
vibratome.   For primary antibody staining, tissue slices were placed in vials 
containing 2mL of antibody buffer (10 % (v/v) goat serum (Vector Labs), 2 % (v/v) 
Triton X-100, and 0.2 % (w/v) sodium azide) with 1:750 mouse anti-neun 
antibody (Millipore; MAB339), and 1:5,000 guinea pig anti-VGlut2 antibody (R&D 
Systems; AF1042) The tissue was incubated in the primary antibody solution for 
24 hours on a nutating mixer.  This was followed by a 30-minute wash in PBS.  
Next, the tissue was placed into a secondary solution consisting of antibody 
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buffer and 1:1,000 red anti-guineau pig (Invitrogen; A11076) and 1:1,000 blue 
anti-mouse (Invitrogen; A21049), and incubated for 2 hours.  Next, another 30-
minute wash in PBS preceded the placement of the tissue onto microscope 





The proto-oncogene c-Fos, which is robustly expressed in neurons 
following the firing of action potentials, was used as a tool to understand the 
extent of neural activity following induction of CMI.  As it is upregulated from 60 
to 90 minutes following neuronal activity, immunolabeling of c-Fos could reveal 
which neurons are responding to the vibrissa stimulation paradigm. 
Immunohistochemistry was applied to label c-Fos in three mice for each 
time frame in this study.  All mice were implanted with chronic thin-skull windows 
and habituated to fixation in the imaging apparatus as described previously.  
Vibrissa stimulation was utilized to locate dilating arterioles in the barrel cortex to 
target for occlusion.  Three control mice were given sham occlusions, with focal 
green laser exposure but no Rose Bengal injection.  Photothrombotic occlusion 
was induced in nine mice, three for each post-CMI time period.  Prior to 
perfusion, mice were exposed to an 8hz train of 35 PSI air puffs to the 
contralateral vibrissa pad for 20 minutes.  Mice were sacrificed and perfused as 
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previously described 75 minutes after stimulation.  Mice with sham strokes were 
perfused on the day of the sham stroke, while the mice with CMIs were sacrificed 
at 48 hours (acute), 7 days (subacute), and 14 days (chronic).   
Following perfusion, the brains were extracted and cortices of both 
hemispheres were flattened between microscope slides and submerged in 4% 
paraformaldehyde as previously detailed.  For immunohistochemistry 
fluorescence labeling, tissue was first placed for 24 hours in a primary antibody 
labeling solution consisting of 1:500 rabbit anti-c-Fos (Santa Cruz Biotech; sc-
52), 1:750 mouse anti-neun antibody (Millipore; MAB339), and 1:5,000 guinea 
pig anti-VGlut2 antibody (R&D Systems; AF1042) in antibody buffer.  After a 30 
minute wash, tissue was added to the secondary antibody labeling solution which 
consisted of 1:1,000 red anti-rabbit (Invitrogen; A11076), 1:1,000 green anti-gp 
(Invitrogen; A31268), and 1:1,000 blue anti-mouse (Invitrogen; A21049).  For 
labeling c-Fos, the color red was selected over green due to the chance that 
residual FITC in the tissue could lead to inaccuracies when counting cells 
containing c-Fos.   
This tissue was then mounted on slides using Fluoromount-G, and images 
were taken at 4x and 10x using a Leica fluorescence microscope.  The locations 
of barrels within the barrel cortex were established using the VGlut2 staining and 
these parameters were taken into account when using a cell-counting macro in 
ImageJ, ITCN (Image-Based Tool for Counting Nuclei) to determine density of c-





Sensory-Evoked Arteriole Dilatory Response in Awake  Mice 
 
To assess the nature of evoked dilations in the healthy animal, data 
gathered during the pre-occlusion imaging phase was pooled together.  A plot of 
the average dilatory response of arterioles and venules to the three stimulation 
conditions is shown below, in Figure 9 .  These traces were generated by 
compiling the average responses from all vessels imaged during the pre-
occlusion period throughout the entire study.  Vibrissa stimulation elicited a 
robust dilatory response, which was followed by an extended, steady-state 
dilation after the cessation of stimulation.   
In contrast, tail stimulation as a control for general arousal resulted in brief 
arteriole dilation, which returned to baseline before the termination of stimulation.  
The specificity of vibrissa-evoked dilation suggested that arterioles sampled were 
within the barrel field of the primary sensory cortex.  Although previous research 
has indicated venules exhibit a “bagpipe” capacitive effect following prolonged 
vibrissa stimulation, we found no evidence of venular dilation in this study under 




Figure 9.  Average Responses of Arterioles and Venu les to Stimulation under Basal 
Conditions.  
Average diameter traces were calculated by averaging the traces for vibrissa stimulation, tail 
stimulation, and no stimulation from all arterioles and venules in pre-stroke conditions.  Shading 
around the trace indicates standard error of the mean. 
 
 The average maximum dilatory response to vibrissa stimulation in 
arterioles resulted in a 23.6 ± 5.9% increase in diameter, while the average 
diameter during the course of stimulation was dilated 9.7 ± 3.4% over baseline 
values.  In contrast, tail stimulation yielded an average maximum dilatory 
response of 4.1 ± 1.3µm and an average mean dilation of 1.5 ± 0.6µm.  As has 
been found in previous studies(76), there was a negative correlation (r = -0.39, p 





Figure 10.  Maximum Dilatory Responses of Individua l Arterioles to Stimulation under 
Basal Conditions.   
There was no significant correlation between tail stimulation or no stimulation dilations and the 
baseline diameter.  There was a significant negative correlation between the baseline diameter 
and the maximum dilation over baseline (r = -0.4422, p = 0.01) 
 
 
Cerebral Microinfarcts were targeted to the Periphe ry of the Barrel 
Cortex 
 
Following chronic imaging, mice were perfused and the brain tissue was 
labeled with IHC to determine the nature and location of CMIs generated by the 
photothrombosis in this study, as shown in Figure 11D .  The average radius of 
the generated strokes was 192 ± 57.6 µm.  As indicated in Figure 11E , VGLUT2 
labeling of the barrel cortex revealed that strokes were concentrated around the 
peripheral barrel cortex.  The microinfarcts were strategically placed surrounding 
33 
 
the core barrels of the vibrissa field such that the gradient of their effect could be 
visualized over the imaging field. 
 
Figure 11.  Locations of Imaging Regions and Cerebr al Microinfarcts Within the Barrel 
Cortex 
(A)  The imaging window was situated over the left hemisphere vibrissa cortex, contralateral to 
stimulation.  (B)  4x 2-Photon vasculature map showing the site of occlusion and three regions of 
interest.  (C)  20x 2-Photon images of the regions of interest with yellow boxes indicating ROIs 
used for calculating vessel diameters.  (D)  VGLUT2 staining of the barrel cortex showing the 
location of a CMI.  The location of the ROIs was transposed to this image using fiducials in the 
histology.  (E)  Location of CMIs within the barrel cortex, with the general imaging region 




Changes in Dilatory Response Following Cerebral Mic roinfarct 
 
To assess changes in dilatory response following CMI, the stimulus 
responses from all viable vessels (those that could be located and identified in all 
time periods following occlusion) were averaged to provide a mean trace for the 
characteristic dilatory responses exhibited by arterioles over time.   
 
Figure 12.   Average Dilatory Response of Arterioles Before and Following Occlusion.  
(A)  Average dilatory response of arterioles to the three stimulus condition presented.  (B)  Mean 
dilation over baseline was significantly attenuated in the acute phase, followed by significant 
recovery in the subacute and chronic phases.  (C)  Zoom-in of the first few seconds of stimulation 
reveals an increased latency to dilation in vessels during the acute and subacute time periods. 
 
Following CMI, in the acute time phase there were obvious changes in the 
dilatory response to all forms of stimulation.  Although there was still a small 
average dilatory response to vibrissa stimulation, the response is very brief and 
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greatly attenuated.  Also, there is no evidence of a steady state response in the 
acute time phase. Further, tail stimulation produced no noticeable dilation.   
When the same vessels were imaged again in the subacute time phase, a 
robust average dilation was restored in the vessels with a small steady-state 
response, albeit attenuated in magnitude compared to baseline.  This was also 
evident in the chronic time-phase, when a small response to tail stimulation also 
returned.  Taken together, this data suggests that there is a near-complete loss 
of dilatory response in the acute time phase, which partially recovers in the 
subacute time phase. 
To give statistical power to the observations made concerning the average 
dilatory traces, the data from this study was compiled using a second method.  
The average trace across all viable trials for each vessel in each time frame was 
generated using the custom program.  Baseline diameter, average dilation over 
baseline, maximum dilation over baseline, and latency to dilation were 
determined for each trace, and this data was compiled for each time frame for 
vessels from the same population of arterioles which could be visualized through 
all time frames.  Shown in Figure 13 , mean dilation over baseline during pre-
stroke imaging was 9.8%, which significantly dropped to 1.8% in the acute time 
phase, followed by a recovery in the subacute and chronic phases during which 
the mean dilation was 7.6% and 7.1% respectively.  Similarly, a significant loss of 
maximum dilatory capacity was also observed in the acute time phase, followed 
by significant recovery in the subacute and chronic time phases, as shown in 
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Figure 10 .   Additionally, there was a significant increase from pre-occlusion 
values in latency to dilation during the acute and subacute time periods.  This 
was followed by a significant recovery of latency to dilation during the chronic 
time period. 
 
Figure 13.  Mean Latency of Dilation is Augmented i n the Acute and Subacute Time 
Periods.   
Using a two-tailed t-test, the latency to dilation was compared between time periods.  As 
indicated in the graph, pre-occlusion values were significantly lower (p < 0.01) than those in the 
acute and subacute time periods.  Likewise, the mean latency in the chronic time period was 
significantly lower (p < 0.01) than in the acute and subacute time periods. 
 
In previous studies, an inverse correlation has been noted between 
maximum dilation over baseline and the baseline diameter of an arteriole (76)  
When maximum dilation over baseline was plotted against the baseline diameter, 
the same correlation was found in the pre-CMI time period of this study; however 
the correlation is completely abolished in acute time phase.  There is partial 
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recovery of this trend later in the study, as the correlation re-emerged in the 
subacute and chronic time phases, albeit with a wider spread of responses. 
 
 
Figure 14.  Loss of Dilatory Response in the Acute Time Phase effects both Small and 
Large Vessels. 
(A)  In the acute time phase, there was a positive correlation between baseline vessel diameter 
and the preserved dilatory response, however, the dilatory function of both small and large 
vessels was significantly attenuated in the acute time phase (B). 
To determine whether the magnitude of the mean dilatory response might 
exhibit the same negative correlation to baseline diameter, the mean change in 
dilation from baseline was plotted against the baseline lumen diameter.  In the 
pre-occlusion phase, there was a negative trend, but no significant correlation in 
contrast to what was observed with maximum dilation diameters, as shown in 
Figure 14A .   Interestingly, a strong, positive correlation emerged in the acute 
phase, indicating that larger vessels may be capable of preserving greater 
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dilatory capacity.  Although this trend was not preserved in the subacute and 
chronic phases, it points to the interesting conclusion that the effects of CMI may 
be more deleterious for neurovascular coupling in smaller vessels.  In the acute 
phase there were a number of vessels that responded to vibrissa stimulation with 
a net negative dilation, potentially due to vascular steal. 
To probe whether small vessels may have a different outcome than large 
vessels following CMI, the vessels were separated into two sub-populations, 
those less than and those greater than 25µm in baseline diameter.  Indicated in 
Figure 14B , there was a significant loss in mean dilatory response in both sets of 
vessels during the acute time-phase followed by significant recovery in the 
subacute and chronic phases, indicating that the dilatory response for both sets 
of arterioles was similarly impacted following CMI. 
 
Correlations between Changes in Dilatory Response a nd Position 
Relative to CMI 
 
Dilatory responses were measured in vessels that covered a wide range 
of distances from the sites of targeted photothrombotic occlusions.  As a strong 
loss of dilatory response was observed in the composite data from all vessels, 
varied locations of sampled vessels could elucidate whether this loss of dilatory 
response was a broad effect, or whether the bulk of changes in dilatory capacity 
took place in the immediate vicinity of the CMI.  Shown in Figure 15A , the 
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dilatory responses for vessels, normalized to the pre-occlusion responses from 
the same vessels, were plotted against the distance from the putative stroke 
border as determined by 4x two-photon maps and VGlut2 IHC.   
 
Figure 15.  Loss of dilatory response extended far beyond the CMI border during the acute 
time phase. 
(A)  While vessels far outside of the CMI border were impacted in the acute time phase, there 
was a correlation between distance from the border and retained dilatory capacity.  This trend 
was preserved through the subacute phase, indicating that distal vessels were impacted to a 
lesser extent and recovered quicker.  (B)  While both proximal and distal vessels saw significant 
decreases in dilatory capacity, there was significant recovery in distal vessels during the acute 
phase, while proximal vessels did not significantly recover until the chronic phase.  (C)  The 
region of deficit extended far beyond the stroke border in the acute time phase. 
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There was a significant positive correlation between the distance from the 
CMI border and the preserved dilatory capacity of arterioles during the acute and 
subacute time periods, indicating that vessels further from the border were more 
likely to preserve dilatory responses in those particular time frames.   
To analyze whether distal and proximal vessels were differentially affected 
by CMI, the vessels analyzed in this study were broken into two groups, 
proximal, which were vessels within 100µm of the CMI border, and distal 
arterioles, located greater than 100µm away.  The cut-off distance for this 
analysis was situated just outside of the overt CMI border, to account for a 
narrow ring of gliotic, non-normal tissue surrounding the CMI core.  Arterioles 
within this cut-off included those in the immediate peri-infarct as well as the few 
viable arterioles within the CMI core.  Both data sets saw a significant decrease 
in dilatory response; however, while distal arterioles exhibited a significant 
recovery beginning in the subacute time phase, proximal arterioles did not show 
significant recovery from acute dilatory responses until the chronic time phase.  
This indicates that both proximal and distal arterioles are similarly impacted by 
CMI in the acute time phase, but distal arterioles exhibit a quicker, more robust 
recovery in the subacute and chronic time phases.  Nonetheless, this indicates 
that the loss of dilatory response extends far beyond the borders of the CMI 
during the early days following occlusion. 
Change in latency, which was calculated as the change in time, in 
seconds, from latency to dilation for a given vessel during pre-occlusion imaging, 
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was also plotted against distance from the CMI border for all three post-stroke 
time phases in Figure 16A .   
 
 
Figure 16.  Both proximal and distal vessels experi enced increase in latency to dilation 
following stroke.  
(A)  There was a negative correlation between distance from CMI border and increase in latency 
to dilation during the acute and subacute time periods, indicating that vessels proximal to the 
stroke were slower to dilate.  (B)  Both proximal and distal vessels exhibited increased latency to 




With this data, a strong negative correlation between distance from stroke 
border and change in latency was found in the acute and subacute time phases, 
indicating that vessels closer to the core of the CMI exhibited a greater latency to 
dilation.  However, when latency data was broken into proximal and distal 
groups, both sets of data exhibited significant augmentation in latency to dilation 
in the acute and subacute time periods, followed by significant recovery in the 
chronic time period, indicating that CMIs are capable of broadly disrupting 
temporal neurovascular coupling. 
 
Genesis of a Deficit – Neurovascular Coupling in Hy per-Acute Stage 
of Cerebral Microinfarction 
 
To gain a better understanding of the means by which neurovascular 
deficits evolve from the initial occlusion to the broad effects measured at the 
acute phase, a separate, small cohort of mice were utilized to model the 
neurovascular hyper-acute (20 min. to 3 hrs. post-occlusion) time period 




Figure 17:  Neurovascular Coupling is Disrupted Pro ximal to Stroke in the Hyperacute 
phase. 
A.  Mean dilation over baseline rapidly diminished in repeatedly measured arterioles in the first 
three hours following microvascular occlusion.  B.  This loss of dilatory capacity is reflected in the 
average traces for arteriole dilation.  C.  Following targeted occlusion, there was a significant 
correlation between proximity to the occluded vessel and loss of dilatory function.  This 
correlation became more pronounced over the course of hyperacute imaging. 
 
  As early as 20 minutes following the occlusion, dilatory deficits were found 
in many arterioles within 150µm of the occluded vessel.  One hour following 
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occlusion, the dilatory deficit extends to 300µm from the occluded penetrating 
arteriole. 
 
Isoflurane and c-Fos – Tools to Probe the Mechanism s of the Loss of 
Dilatory Response 
 
The widespread loss of dilatory response found in the acute time phase 
indicates that there is at least a temporary breakdown of neurovascular coupling.  
This could be attributable to a number of factors, as there are a number of 
components that drive neurovascular coupling in the neurovascular unit.  In this 
study, we chose to investigate the two candidates that are seemingly the most 
likely to be the source of this deficiency and the two principal components of the 
neurovascular unit, the sensory neurons which respond to stimuli, eventually 
driving vascular activity, and the vascular wall itself.  To probe for deficits in 
neuronal activity, c-Fos, a proto-oncogene upregulated following extensive 
neuronal activity, was utilized to quantify neurons responding to the stimulus 
paradigm used in this study (77).  Changes in vascular wall compliance were 
investigated using Isoflurane, a volatile anesthetic common in veterinary 




Figure 18.  Isoflurane is capable of inducing far l arger dilations than vibrissa stimulation. 
Full-Width Half-Maximum measurements across the same arteriole reveal that isoflurane 
exposure induces dilations that exceed the dilatory response seen during vibrissa stimulation. 
Isoflurane was administered to mice following imaging sessions at a 
concentration of 3.0% in air for 3 minutes.  During this brief period of exposure, a 
movie was collected across all imaging regions to capture the extent of dilation 
during isoflurane exposure.  The average dilation over baseline during isoflurane 
exposure was much greater than the maximum dilations achievable with the 
vibrissa stimulation paradigm during all time periods, indicating the vascular wall 
was capable of dilating well beyond the attenuated dilations seen following CMI.   
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Although this indicates that vascular wall stiffening cannot be the sole source of 
the loss of dilatory response, a significant decrease in isoflurane-induced 
dilations over baseline was evident in the acute phase, pointing toward vascular 
wall compliance issues as a potential contributing factor.  
 
Figure 19.  Dilations induced by isoflurane exposur e were significantly attenuated in the 
acute phase, but still greatly exceeded the dilator y response to vibrissa stimulation. 
Isoflurane was capable of dilating arterioles well beyond the maximum dilatory responses to 
stimulation during all time periods in this study.  While there is a significant decrease in isoflurane 
induced dilation diameters in the acute time phase, these results indicate that it is unlikely that 
changes in vascular wall compliance are the only contributing factor to the loss of sensory-




Figure 20.  Immunofluorescence staining of c-Fos re veals robust neuronal activation in the 
barrel cortex contralateral to vibrissa stimulation  in a sham animal. 
 In sham CMI animals, c-Fos was homogenously expressed at low levels 
throughout cortex ipsilateral to vibrissa stimulation, with a slight elevation in the 
primary vibrissa cortex.  In the contralateral cortex, however, c-Fos was robustly 
expressed in the barrel cortex. 
When mice were perfused during the acute time period following 
occlusion, the expression of c-Fos was reduced in a broad region of cortex 




Figure 21.   c-Fos activation in the barrel cortex contralateral to vibrissa stimulation is 
diminished in the acute phase following CMI. 
Following CMI, the number of c-Fos+ cells in the barrel cortex is greatly reduced in the acute 
phase.  As the CMI progresses into the subacute and chronic time periods, more cells were c-
Fos+ in the peri-infarct cortex following prolonged vibrissa stimulation. 
In mice that were sacrificed during the subacute time period, c-Fos levels 
began to recover from the acute deficit, with the region of inactive neurons 
extending only 200-400µm outside of the putative stroke border, shown in Figure 
22.  By the chronic time period, the expression of c-Fos had recovered even 
further, as many neurons within the peri-infarct strongly expressing the proto-
oncogene following prolonged sensory stimulation.  This data points toward a 





Figure 22.  Expression of c-Fos is attenuated proxi mal to the CMI in the acute and 
subacute phases. 
(A&B)  A 100µm x 500µm ROI was placed to sample cfos activity as a function of 
distance from CMI.   Another ROI was placed across the barrel cortex of a sham animal, 
covering the same barrels, to provide a control for basal stimulation expression.  (C) c-
Fos expression was reduced proximal to the CMI when compared to the control across 






The impact of microvascular lesions, as often observed in the aging 
human brain, on neurovascular coupling is currently not well understood.  To 
probe this issue, we have utilized a mouse model of microinfarct pathology based 
on selective occlusion of individual penetrating arterioles and venules in the 
mouse barrel cortex.  Neurovascular coupling was first assessed longitudinally by 
two-photon imaging of arterioles during vibrissa stimulation using air puffs during 
four time-periods: pre-occlusion, acute (2-3 days post occlusion), subacute (7-9 
days post occlusion), and chronic (14-21 days post occlusion).  The mean 
dilation from baseline diameter was significantly attenuated during the initial 
acute imaging period.  Despite being relatively small in size (≈400µm in 
diameter), CMIs generated in this experiment were capable of eliciting a 
widespread and persistent dilatory deficit in the surrounding cortex, with deficits 
occurring in arterioles up to 1mm outside of the putative stroke boundary.     
The widespread impact of these targeted microvessel occlusions is likely 
attributable to the process of diaschisis, a term coined by van Monakow in 1914 
to describe neurophysiological changes that occur distant to a focal brain 
lesion(79).   These neurophysiological phenomena can be classified into two 
categories:  Focal diaschisis, and connectional diaschisis.  Focal diaschisis might 
occur during cortical strokes as the result of white matter tract degeneration in 
underlying subcortical tissue.  While the microinfarcts induced in this study are 
unlikely to cause any form of extensive subcortical damage, it should be noted 
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that diffusion MRI studies in clinical stroke patients revealed that subcortical 
disconnection extends well beyond the locus of tissue necrosis, affecting major 
white matter pathways (80).   
In the case of the targeted photothrombotic occlusions generated in this 
stroke model, it is more likely that expansive dilatory deficit is an example of 
connectional diaschisis, which encompasses changes in structural and functional 
connectivity between the lesion area and distal brain regions.  While the barrel 
cortex is functionally segregated into barrels directly associated with individual 
vibrissa, there is still a high level of interconnectivity between barrels.  Regular 
spiking pyramidal cells in layer 5 are tuned to respond to activity in surrounding 
barrels(81), while neurons in layer 2/3 also exhibit a high level of connectivity to 
surround barrels (82).  Disruption of this inter-barrel connectivity could 
conceivably be contributing to the loss of neurovascular coupling in the days 
following CMI.  A possible mechanism of this alteration in barrel-to-barrel 
connectivity may be remodeling the axon initial segment (AIS).  AIS length is 
acutely decreased in the peri-infarct cortex, particularly affecting neurons with 
distal axons projecting in the infarcted area(42).  The decrease in length occurs 
at the distal AIS, as axons essentially retract from the infarcted tissue, likely 
driving cortical reorganization.  One limitation of the photothrombotic stroke 
model utilized is the potential for non-focal activation of intravenous rose-Bengal 
dye during targeted green laser illumination.  Diffuse light below and adjacent to 
the site of occlusion could be causing low-level activation of rose Bengal dye, 
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generating free-radicals which could contribute to the ischemic damage observed 
well outside the infarcted tissue both in this study and in other studies utilizing 
photothrombotic stroke models.  In addition to connectional diaschisis, 
widespread BBB breakdown observed in cortex during the subacute and chronic 
time periods both contralateral and ipsilateral to focal stroke may contribute to 
the broad effects of diaschisis(83, 84).  
At the subacute imaging time frame, vessels exhibited significant, albeit 
incomplete, recovery from the dilatory deficit of the acute phase.  Proximal 
vessels (those within 100µm of the putative stroke border) did not exhibit 
significant recovery of dilatory capacity during this time frame, indicating that 
deficit is likely prolonged in arterioles closer to the site of infarction, which is also 
suggested by a strong positive correlation between the distance from the stroke 
and the relative level of preserved dilatory capacity in the subacute phase.  
Previous research has provided evidence of broad hyperexcitability during the 
subacute phase in brain regions both ipsilateral and contralateral to ischemic 
stroke(85), which may drive the functional recovery of mean dilatory capacity in 
arterioles distal to the microinfarct.  Electrophysiological paired-pulse studies in 
rat brain slices have shown extensive hyperexcitability in the contralateral 
hemisphere, as well as ipsilaterally as close as 1mm away from infarcted tissue.      
Hyperexcitability has also been found seven days post occlusion with 
optogenetic mapping utilizing ChR2-evoked voltage sensitive dye responses(86).  
It should also be noted that, in the same study, regions distal to the infarct 
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exhibited upscaling of the evoked response, while connectomics analysis 
indicated that neurons closely connected to the peri-infarct were damaged 
whereas areas with little peri-infarct connection escaped damage, provide 
rationale to the often heterogeneous recovery observed in the tissue surrounding 
a stroke.  While overt hyperexcitability was not detected in the form of an 
enhanced dilatory response, distal arterioles were more likely to preserve dilatory 
function in the acute phase, and exhibited significantly greater recovery in the 
subacute phase when compared to proximal arterioles.  At the chronic time 
period, arterioles proximal to the CMI exhibited significant, yet incomplete, 
recovery of dilatory capacity from the acute deficit, which in effect abolished the 
correlation between dilatory function and proximity of arterioles to the infarct.  
This may indicate the recovery of neurovascular coupling in the spared cortex by 
way of functional reorganization and synaptogenesis. 
The rapid, local deficit observed in the hyperacute experiment could be 
attributed to a number of mechanisms initiating in the early onset of stroke.  In a 
model of focal ischemia, brain regions that exhibited severe ischemia (<10% of 
original CBF maintained) underwent rapid loss of spine and dendritic structure in 
as little as 10 minutes(87).  The ensuing rapid spread of neurovascular 
decoupling is likely driven by secondary damage and proliferation of the stroke, 
initiated with the rapid release of ROS and pro-inflammatory mediators from 
apoptotic cells in the ischemic tissue(88).  These mediators activate microglia, 
which are endogenously held in check by tonic inhibitory signaling, 
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morphologically altering the cells from a ramified to an amoeboid morphology 
and releasing inflammatory cytokines and chemokines which can exacerbate or 
conversely help repair ischemic injury(62).  Specifically, the increased levels of 
cytokines and chemokines facilitate adhesion and trans-endothelial migration of 
circulation leukocytes(89).  These infiltrating leukocytes may release pro-
inflammatory mediators, including cytokines, chemokines, and ROS which 
contribute to the evolution of tissue damage(90) and drive the infiltration of 
various inflammatory cells, including neutrophils, t-cell subtypes, and additional 
monocytes and macrophages(91).  In addition to the biochemical impact of rolling 
leukocytes within the microvasculature, leukocyte adhesion might mechanically 
limit vascular perfusion of the infarcted tissue, as frequent flow stagnation of 
deep cortical capillaries has been observed due to leukocyte plugging in a mouse 
model of hypoperfusion(92). 
In addition to the deficits seen in dilatory capacity, targeted CMIs also 
appeared to impact neurovascular coupling by significantly prolonging the latency 
to dilation during vibrissa stimulation in both the acute and subacute time 
periods.  There was also a significant correlation between the proximity of 
arterioles to the CMI and the increase in latency to dilation, indicating that, in 
addition to causing broad dilatory deficits, CMIs have a stronger deleterious 
effect on temporal neurovascular coupling in arterioles proximal to the infarct.  
This adjustment in temporal neurovascular coupling may reflect the ongoing 
process of axonal rewiring during recovery from ischemic stroke, which is 
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facilitated by inhibition of growth inhibitory molecules in the peri-infarct for up to 1 
month following injury.  Axonal rewiring occurs in three phases following 
stroke(93).  In the early phase, from days 1 to 3, rhythmic and synchronized 
neuronal discharges, similar to those in the developing brain, induce axonal 
sprouting.  Starting at day 3, genes for growth cone lipid raft proteins GAP43, 
Cap23, and MARCKS as well as the transcription factor c-Jun are induced and 
persist through the duration of the sprouting process(94).  The increased latency 
to sensory induced dilation present in the acute phase, and persisting to the 
subacute phase, could be attributed to shifting functional connectivity.  Axons 
projecting into the region of infarction are pruned, while immature spines forming 
on surviving neurons in the peri-infarct have yet to establish strong functional 
connections, leaving a relatively disjointed system that is slow to respond to 
stimulus.  In the middle phase of the sprouting response, cell adhesion molecules 
help guide the sprouting response and form new connections.  The final stage of 
the sprouting process involves cytoskeletal reorganization genes SCG10 and 
SCLIP, which aide in the maturation of the sprouting process.  This final 
maintenance phase initiates 7-14 days post ischemia, and results in the 
formation of an anatomically distinct pattern of connections(93). 
To further investigate our findings, we utilized two assessments to 
ascertain whether the source of the deficits might be attributable to alteration in 
vascular mechanics, or in neuronal signaling.  Vascular alterations occurring in 
the early stages following stroke include the adoption of tortuous morphologies in 
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penetrating vessels(95), leukocyte rolling and adhesion(92), and swollen and 
vacuolated endothelial cells(83), all of which can impact CBF.  Acute isoflurane 
administration was performed before occlusion, and in the acute, subacute, and 
chronic phase to investigate whether endothelial cell alterations might 
mechanically inhibit vascular dilation.  Isoflurane induced dilations were 
significantly attenuated in the acute time phase, coinciding with the most 
significant dilatory deficits, however, there was recovery to baseline in the 
subacute and chronic phases.  Isoflurane induces vasodilation of cerebral 
vessels at least partially through the activation of ATP-sensitive K+ channels on 
the endothelial cells(78), a pathway also present in the neurovascular signaling 
unit(15).  A reduction of these receptors, or a deficit in endothelial cell reactivity 
to them, may contribute to the dilatory deficit observed in the peri-infarct following 
cerebral microinfarction.  In addition, it has been found that vascular smooth 
muscle F-actin is reduced following 1 hour of middle cerebral artery occlusion, 
which could be promoting vascular damage and limiting vascular wall 
compliance(96). 
Due to the complexity of neurovascular coupling, we used the proto-
oncogene c-Fos, which is upregulated following strong neuronal activation, as a 
simple probe to determine whether viable neurons in the peri-infarct were 
capable of responding to sensory stimuli.  c-Fos expression was greatly reduced 
in the acute mouse, with severe deficits extending up to 1mm from the ischemic 
stroke core.    While previous studies have indicated that endogenous c-Fos is 
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briefly upregulated following focal ischemia(97, 98), with peak values occurring at 
60 minutes post occlusion, the time point used for this study does not coincide 
with these findings, and no upregulation of c-Fos activity is indicated in our 
results.  Instead, widespread deficits that present acutely persist into the 
subacute time phase, indicating poor neuronal connectivity during a period of 
synaptogenesis and neuronal rewiring. 
The results of this study help to shed light on the microvascular 
environment and on alterations in neurovascular coupling at the level of 
individual vessels, and provide a microvascular correlate to previous BOLD fMRI 
findings.  The data in this study reveals that CMIs, though small in size, can 
impact neurovascular coupling in a broad region of cortex, elucidating a 
mechanism by which microinfarcts may cause cognitive impairment.  As CMIs 
have previously been associated with dementia in the elderly, these findings 
indicate that the neurovascular unit, in addition to being a crucial component in 
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